Glaucoma suspect clinical trials
8 active trials name this condition. Describe your situation to see which ones you may be eligible for.
- Measuring the Effects of Netarsudil, Latanoprost, and Combination Therapy on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma Suspects
- Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use
- Glaucoma Laser Assessment of Stability and Sustainability
- Automated Applanation Tonometry - Updated
- Optic Nerve Head Strain in Non-glaucoma Subjects
- Diagnostic Innovations in Glaucoma Study
- Know Your Pressures NYC
- CLAD Deconvolved PERG Responses in Glaucoma Patients
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Glaucoma suspect” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.